Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
1.41 %
$ 4.6 B
Market Cap
-295.5
P/E
TGTX - OPERATING INCOME
Operating Income TGTX - TG Therapeutics, Inc.
20.6 M
LAST VALUE
43.52%
2 YEAR CAGR
16.20%
5 YEAR CAGR
11.23%
10 YEAR CAGR